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ABSTRACT 
EVALUATION OF TUMOR INFILTRATING LYMPHOCYTES  
IN BREAST CANCER 
Background:  
Tumor infiltrating lymphocytes (TILs) were evaluated in many cancers like 
ovarian tumors, endometrial tumors, colon cancer and melanoma. Now there is 
increasing trend in evaluating TILs in breast cancer. Tumor infiltrating lymphocytes 
gives the patients immune response to the tumor. 
Methods : 
100 cases of Modified radical mastectomy specimen were chosen from 
surgical pathology records which are received during the period of January 2013 to 
December  2015.  The representative formalin fixed paraffin embedded tissue samples 
were collected. Detailed history regarding Patient’s age, sex, side of the breast 
involved, Grade, Lymph node involvement, neo-adjuvant chemotherapy and 
Hormonal status like status of Estrogen Receptor, Progesterone Receptor, HER2neu 
were assessed for 100 cases. Tumor Infiltrating Lymphocytes are evaluated with 
Immuno HistoChemistry CD45 and CD3 for 100 cases , in which  93% cases were  
Infiltrating Ductal carcinoma-NOS cases and 07 % cases are of special types like 
Mucinous, Metaplastic, Apocrine, and Medullary carcinoma. 
 
Results: 
In our study, Highest incidence of breast carcinoma occur in the age 
group of 41-50 years. Infiltrating  Ductal Carcinoma NOS  is the most common 
primary malignant neoplasm of breast constituting 93% of cases.  Most of the 
malignant tumors are left sided. Forty seven percent of cancers are presented in 
the size range of 2-5cms.  Majority of the tumors are of Grade II accounting for 
63.5% of all cases.  
TILs were evaluated with three variables 0- 10 %  20- 40 % and 50- 90 
%.Younger the age, more the TILs. Neo adjuvant chemotherapy had significant 
correlation with TILs (P= 0.05).  Grading for these cases correlated well with TILs ( 
P= 0.05). Triple Negative tumors and ER+ and PR + have strong association with 
TILs.  
Conclusion:  
Tumor Infiltrating Lymphocytes have correlated well with neo- adjuvant 
chemotherapy and grading of breast cancers. Triple negative breast cancers have 
strong association with TILs. 
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